RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Microarray technology had a troubling beginning, but many problems resulted from the growing pains of this technology that, like many new things, was initially more promise than delivery. However, the promise has finally come to fruition, and microarray technology has developed into a mature technology that can generate valid and useful results in basic, translational, clinical trials, and now clinical practice. Much maturity resulted from the realization that microarrays are not some magic tool, but rather are like any other measurement device and that unless microarray experimentation is coupled with good experimental practices, it will not yield valid results or, worse yet, may lead to misleading results.
